Coordination and planning of clinical research on a national and global level.
Cooperative Behavior
Data Accuracy
Endpoint Determination
Evidence-Based Medicine
Female
Fertility
Humans
Infertility
/ diagnosis
International Cooperation
Live Birth
Male
Multicenter Studies as Topic
Pregnancy
Randomized Controlled Trials as Topic
Reproductive Medicine
Research Design
Stakeholder Participation
Treatment Outcome
Core outcomes
Global South
clinical trials
meta-analysis
reproductive medicine
Journal
Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
12
02
2020
revised:
14
04
2020
accepted:
14
04
2020
entrez:
3
6
2020
pubmed:
3
6
2020
medline:
17
2
2021
Statut:
ppublish
Résumé
In reproductive medicine, the needs and desires of infertility patients drive future research, with the most important outcome being live birth of a baby. Large, multicenter, randomized clinical trials are considered the best research tool to evaluate the effectiveness of medical interventions, but they can often take a long time to find definitive answers. Advances in individual participant data (IPD) and network meta-analysis have enabled research questions to be answered more quickly, but better planning could streamline this process further. To harmonize research findings that are taking place globally in this way, it is crucial that the same outcomes are collected in clinical trials conducted in reproductive medicine. Furthermore, the conduct of clinical trials often requires collaboration on an international scale; however, individual countries have their own processes for research prioritization and delivery. We describe the perspective of high- and low-resourced settings and industry as well as the mechanisms of prioritization and coordination that are in place in different settings. In addition, we discuss the importance of the patient perspective, which can help shape the research question, clinical trial design, and the logistical operations of trial delivery. The need for increased global collaboration and coalitions within and between stakeholders is evident for the research community to accelerate advances and maximize benefits in reproductive medicine.
Identifiants
pubmed: 32482245
pii: S0015-0282(20)30393-9
doi: 10.1016/j.fertnstert.2020.04.032
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1100-1106Informations de copyright
Copyright © 2020 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.